Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview

4306studies shown

Showing 4,033-4,044 of 4,306

Active Not RecruitingNCT07092826

OCD: Insight, Trauma, and Links to Schizophrenia Spectrum Disorders

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Parma

Why is this study shown?

This study includes Schizophrenia among several conditions.

OCD, SchizophreniaBehavioralFrom 18 Years to 65 Years

Countries: Italy
Sponsor: Matteo Tonna
Condition: OCD, Schizophrenia

View study

CompletedNCT00621777

Varenicline for Prevention of Relapse to Smoking in people with Schizophrenia or Bipolarity

This study is completed in the United States. It is testing varenicline for schizophrenia.

Multiple locations, including Birmingham

Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, SchizophreniaDrugFrom 18 Years to 70 Years

Countries: United States
Sponsor: Massachusetts General Hospital
Condition: Bipolarity, Schizophrenia

View study

CompletedNCT07116694

Assessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Chino

Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, SchizophreniaDrugFrom 18 Years to 75 Years

Countries: United States
Sponsor: BioXcel Therapeutics Inc
Condition: Bipolarity, Schizophrenia

View study

CompletedNCT03526354

Controlled study of Brexpiprazole for Co-occurring Schizophrenia and Addiction

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Augusta

Why is this study shown?

This study includes Schizophrenia among several conditions.

Addiction, SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: University of Massachusetts, Worcester
Condition: Addiction, Schizophrenia

View study

CompletedNCT05658510

Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolarity (SERENITY III)

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Bellflower

Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, SchizophreniaDrugFrom 18 Years to 75 Years

Countries: United States
Sponsor: BioXcel Therapeutics Inc
Condition: Bipolarity, Schizophrenia

View study

CompletedNCT00179062

Effects of Risperidone and Olanzapine on people with Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Nashville

Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, Depression, ...DrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: Vanderbilt University
Condition: Bipolarity, Depression, ...

View study

CompletedNCT00139919

Progressively Decreasing Titration Schedules of Bifeprunox in Subjects With Schizophrenia or Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Orange

Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, SchizophreniaDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Solvay Pharmaceuticals
Condition: Bipolarity, Schizophrenia

View study

CompletedNCT01094249

Valproic Acid and Paliperidone Extended-Release (ER) for schizophrenia

This study is completed in the United States. It is testing Valproic Acid and Paliperidone Extended-Release (ER) for schizophrenia.

Multiple locations, including Kissimmee

Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition: Bipolarity, Schizophrenia

View study

CompletedNCT03630822

Comparative and Prospective Study Evaluating the Impact on the Care Path of an Editorial Program Accompanied by Advance Directives in Psychiatry (DAP) for People Suffering From Schizophrenia, Bipolarity type I or Schizoaffective Disorder

This study is completed in France. It focuses on schizophrenia.

In Marseille

Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, SchizophreniaBehavioralOver 18 Years

Countries: France
Sponsor: Assistance Publique Hopitaux De Marseille
Condition: Bipolarity, Schizophrenia

View study

Not recruitingISRCTN95702682

PARTNERS2: A cluster control study of a model of collaborative care for people with a diagnosis of bipolar, schizophrenia or other psychoses

This study is not recruiting in the United Kingdom. It focuses on schizophrenia.

In United Kingdom

Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, SchizophreniaOtherFrom 18 Years to 110 Years

Countries: United Kingdom
Sponsor: Birmingham and Solihull Mental Health Foundation Trust
Condition: Bipolarity, Schizophrenia

View study

CompletedNCT00709202

Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gain

This summary needs review. Please check the official study record and contact the research team for details.

In Orangeburg

Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, SchizophreniaDrugFrom 18 Years to 59 Years

Countries: United States
Sponsor: Nathan Kline Institute for Psychiatric Research
Condition: Bipolarity, Schizophrenia

View study

CompletedNCT04689867

Cognitive Behavioral Suicide prevention for Psychosis: Aim 1

This summary needs review. Please check the official study record and contact the research team for details.

In Ann Arbor

Why is this study shown?

This study includes Schizophrenia among several conditions.

Suicidality, SchizophreniaBehavioralFrom 18 Years to 65 Years

Countries: United States
Sponsor: University of Michigan
Condition: Suicidality, Schizophrenia

View study

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.